Interpretation on the 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guidelines for the Management of Patients with Chronic Coronary Disease

In July 2023, the American Heart Association (AHA), the American College of Cardiology (ACC), and four other professional societies jointly released the updated version of the AHA/ACC/ACCP/ASPC/NLA/PCNA Guidelines for the Management of Patients with Chronic Coronary Artery Disease. This guideline emphasizes a patient-centered and team-based approach to the overall management of chronic coronary artery disease (CCD), highlights the impact of lifestyle improvements on the prognosis of CCD patients, and provides new insights into risk assessment for major adverse cardiovascular events (MACE) and recommendations for novel medications. These updates hold significant guiding value for health care professionals in China to provide high-quality management for CCD patients..

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:15

Enthalten in:

Xiehe Yixue Zazhi - 15(2024), 2, Seite 312-319

Sprache:

Chinesisch

Beteiligte Personen:

LIANG Yan [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
xhyxzz.pumch.cn [kostenfrei]
Journal toc [kostenfrei]

Themen:

Chronic coronary artery disease
Diagnosis
Guidelines
Management
Medicine
R
Treatment

doi:

10.12290/xhyxzz.2024-0043

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ095881859